149 related articles for article (PubMed ID: 34735298)
1. Abstract MP265: The Role Of Phosphodiesterase 10a In Tumor Growth And Doxorubicin-induced Cardiotoxicity.
Chen S; Chen J; Shi H; Mickelsen D; Yan C
Circ Res; 2021 Sep; 129(Suppl_1):AMP265. PubMed ID: 34735298
[TBL] [Abstract][Full Text] [Related]
2. PDE10A Inactivation Prevents Doxorubicin-Induced Cardiotoxicity and Tumor Growth.
Chen S; Chen J; Du W; Mickelsen DM; Shi H; Yu H; Kumar S; Yan C
Circ Res; 2023 Jul; 133(2):138-157. PubMed ID: 37232184
[TBL] [Abstract][Full Text] [Related]
3. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction.
Chen S; Zhang Y; Lighthouse JK; Mickelsen DM; Wu J; Yao P; Small EM; Yan C
Circulation; 2020 Jan; 141(3):217-233. PubMed ID: 31801360
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
Giampà C; Laurenti D; Anzilotti S; Bernardi G; Menniti FS; Fusco FR
PLoS One; 2010 Oct; 5(10):e13417. PubMed ID: 20976216
[TBL] [Abstract][Full Text] [Related]
6. Emerging biology of PDE10A.
Wilson LS; Brandon NJ
Curr Pharm Des; 2015; 21(3):378-88. PubMed ID: 25159072
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease.
Leuti A; Laurenti D; Giampà C; Montagna E; Dato C; Anzilotti S; Melone MA; Bernardi G; Fusco FR
Neurobiol Dis; 2013 Apr; 52():104-16. PubMed ID: 23220622
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
[TBL] [Abstract][Full Text] [Related]
9. Isorhapontigenin protects against doxorubicin-induced cardiotoxicity
Wang P; Wang M; Hu Y; Chen J; Cao Y; Liu C; Wu Z; Shen J; Lu J; Liu P
Acta Pharm Sin B; 2021 Mar; 11(3):680-693. PubMed ID: 33777675
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 10A Is a Key Mediator of Lung Inflammation.
Hsu CG; Fazal F; Rahman A; Berk BC; Yan C
J Immunol; 2021 Jun; 206(12):3010-3020. PubMed ID: 34117108
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.
Russwurm C; Koesling D; Russwurm M
J Biol Chem; 2015 May; 290(19):11936-47. PubMed ID: 25762721
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a highly specific
Xiao Z; Wei H; Xu Y; Haider A; Wei J; Yuan S; Rong J; Zhao C; Li G; Zhang W; Chen H; Li Y; Zhang L; Sun J; Zhang S; Luo HB; Yan S; Cai Q; Hou L; Che C; Liang SH; Wang L
Acta Pharm Sin B; 2022 Apr; 12(4):1963-1975. PubMed ID: 35847497
[TBL] [Abstract][Full Text] [Related]
13. Interplay of palmitoylation and phosphorylation in the trafficking and localization of phosphodiesterase 10A: implications for the treatment of schizophrenia.
Charych EI; Jiang LX; Lo F; Sullivan K; Brandon NJ
J Neurosci; 2010 Jul; 30(27):9027-37. PubMed ID: 20610737
[TBL] [Abstract][Full Text] [Related]
14. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
[TBL] [Abstract][Full Text] [Related]
15. Selective Effects of PDE10A Inhibitors on Striatopallidal Neurons Require Phosphatase Inhibition by DARPP-32.
Polito M; Guiot E; Gangarossa G; Longueville S; Doulazmi M; Valjent E; Hervé D; Girault JA; Paupardin-Tritsch D; Castro LR; Vincent P
eNeuro; 2015; 2(4):. PubMed ID: 26465004
[TBL] [Abstract][Full Text] [Related]
16. [18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.
Ooms M; Attili B; Celen S; Koole M; Verbruggen A; Van Laere K; Bormans G
J Neurochem; 2016 Dec; 139(5):897-906. PubMed ID: 27664396
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer.
Borneman RM; Gavin E; Musiyenko A; Richter W; Lee KJ; Crossman DK; Andrews JF; Wilhite AM; McClellan S; Aragon I; Ward AB; Chen X; Keeton AB; Berry K; Piazza GA; Scalici JM; da Silva LM
J Ovarian Res; 2022 Nov; 15(1):120. PubMed ID: 36324187
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
